Señales en vivo de NRBO | Maximiza tus Ganancias con Getagraph.com

COMPRAR 115929 min ago

@ $4.65

Emitido: 14 feb 2024 @ 15:13

Retorno: -18.71%

Señal anterior: feb 12 - 09:45

Señal anterior: Vender

Retorno: -4.12 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases...

Stats
Volumen de hoy	22 012.00
Volumen promedio	131 461
Capitalización de mercado	18.54M
EPS	$-2.28 ( 2024-04-04 )
Próxima fecha de ganancias	( $-0.950 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.540
ATR14	$0.0400 (1.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Woodworth Marshall H	Buy	33 496	Common Stock
2023-12-01	Tursi James Patrick	Buy	7 157	Common Stock
2023-12-01	Tursi James Patrick	Buy	25 000	Common Stock
2023-11-01	Tursi James Patrick	Buy	0
2023-10-27	Woodworth Marshall H	Buy	0

INSIDER POWER
34.95
Last 74 transactions
Buy: 14 405 360 \| Sell: 2 893 741

Volumen Correlación

Largo: -0.06 (neutral)

Corto: 0.87 (strong)

Signal:(58.809) Same movement expected

Neurobo Pharmaceuticals Correlación

10 Correlaciones Más Positivas
GRPN	0.809
REE	0.809

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neurobo Pharmaceuticals Correlación - Moneda/Commodity

0.34
( neutral )

0.51
( weak )

0.00
( neutral )

-0.37
( neutral )

-0.62
( weak negative )

Neurobo Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$7 000.00
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.46

FY	2023
Ingresos:	$7 000.00
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.46

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-28 000.00 (0.00 %)
EPS:	$-19.01

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-28.27

Financial Reports:

No articles found.

Neurobo Pharmaceuticals

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Actualizaciones en tiempo real para Neurobo Pharmaceuticals [NRBO]

Upcoming Earnings Alert